Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Sleep Disorder Agents (Find 1 items)

Sort Sleep Disorder Agents Alphabetically

Sleep Disorder Agents

Explore a wide selection of Sleep Disorder Agents Intermediates for pharmaceutical research and production. Access raw materials with detailed CAS numbers, property data, and SDS to support the development of drugs for insomnia, circadian rhythm disorders, and other sleep-related conditions. Source high-quality intermediates from certified suppliers for reliable and safe usage.

6-Methoxy-1-indanone

(13623-25-1)
Indanone derivative as α1-adrenoceptor antagonist.

Product List

Request for quotation , get quotes from more suppliers.

Sleep Disorder Agents intermediates are some key chemical raw materials or products in the synthesis process of sleep disorder drugs. You can easily find high-quality new intermediates, products and their manufacturers or suppliers on ECHEMI. We will always track the research and development of new products on sleep disorder agent.

Source Sleep Disorder Agents Raw Materials by Region

More Information

Sleep Disorder Agents Intermediates are key raw materials used in the synthesis of pharmaceuticals targeting sleep disorders. These intermediates provide the foundation for sedatives, hypnotics, melatonin receptor modulators, and other sleep-regulating agents.

Common applications and types include:
• Sedative intermediates — for calming the central nervous system and promoting sleep onset.
• Hypnotic intermediates — used in treatments for insomnia and sleep maintenance.
• Melatonin receptor modulators — supporting therapies for circadian rhythm disorders.
• Adjunct intermediates — for drugs that enhance sleep quality and reduce sleep disturbances.

Frequently Asked Questions

What are Sleep Disorder Agents?

Sleep Disorder Agents are pharmaceutical compounds used to treat various sleep-related conditions such as insomnia, sleep apnea, narcolepsy, and restless leg syndrome. These agents may include sedative-hypnotics, melatonin receptor agonists, orexin receptor antagonists, and other CNS-acting medications designed to regulate sleep-wake cycles and improve sleep quality.

How do Sleep Disorder Agents work in the body?

Sleep Disorder Agents work through different pharmacological mechanisms depending on their class. For example, benzodiazepines enhance GABA activity to induce sedation, while melatonin agonists like ramelteon mimic the body’s natural sleep hormone. Newer agents such as suvorexant block orexin receptors to reduce wakefulness. Understanding these mechanisms helps clinicians select the most appropriate therapy based on the patient’s specific sleep disorder.

What are common types of Sleep Disorder Agents available on the market?

Common types of Sleep Disorder Agents include:1. Benzodiazepines (e.g., temazepam)2. Non-benzodiazepine hypnotics (e.g., zolpidem, eszopiclone)3. Melatonin receptor agonists (e.g., ramelteon)4. Orexin receptor antagonists (e.g., suvorexant, lemborexant)5. Antidepressants with sedative effects (e.g., trazodone, used off-label)Each class varies in onset, duration, side effect profile, and suitability for long-term use.

What factors should be considered when sourcing Sleep Disorder Agents for pharmaceutical production?

When sourcing Sleep Disorder Agents for pharmaceutical manufacturing, consider:1. Regulatory compliance (e.g., FDA, EMA, or local health authority approvals)2. API purity, stability, and documentation (including CoA and DMF)3. Supplier’s adherence to Good Manufacturing Practices (GMP)4. Scalability and consistency of supply5. Intellectual property status to avoid patent infringementSelecting a reliable supplier ensures product safety, efficacy, and regulatory compliance.

Are there any safety concerns associated with Sleep Disorder Agents?

Yes, Sleep Disorder Agents can carry risks such as dependence, tolerance, next-day drowsiness, cognitive impairment, and complex sleep behaviors (e.g., sleepwalking). Benzodiazepines and Z-drugs may lead to withdrawal symptoms if discontinued abruptly. Newer agents like orexin antagonists generally have lower abuse potential but still require careful patient monitoring. Always follow clinical guidelines and prescribe the lowest effective dose for the shortest duration necessary.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.